Engineers Gate Manager LP Viracta Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.23 - $4.76 $38,090 - $81,305
-17,081 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$3.37 - $7.91 $57,562 - $135,110
17,081 New
17,081 $62,000
Q3 2021

Nov 15, 2021
SELL
$7.84 - $12.53 $78,823 - $125,976
-10,054 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$7.55 - $12.95 $75,907 - $130,199
10,054 New
10,054 $114,000

Others Institutions Holding VIRX

# of Institutions
41
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Viracta Therapeutics, Inc.

VIRX Quotes by TradingView
  • Ticker VIRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,558,200
  • Market Cap $9.39M
  • Description
  • Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...
More about VIRX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email